BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6240117)

  • 1. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased intravascular coagulation associated with pregnancy.
    Gerbasi FR; Bottoms S; Farag A; Mammen E
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular marker for hemostasis and thrombosis].
    Fukutake K; Fujimaki M
    Nihon Rinsho; 1989 Apr; 47(4):883-90. PubMed ID: 2664266
    [No Abstract]   [Full Text] [Related]  

  • 6. Newer techniques in the study of hemostatic disorders.
    Pepper DS; Preston FE; Mibashan RS
    Semin Hematol; 1978 Jan; 15(1):73-92. PubMed ID: 341329
    [No Abstract]   [Full Text] [Related]  

  • 7. The molecular markers of hemostatic activation on coronary artery disease.
    Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
    Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of fibrinopeptide A and D-dimer in diagnostics of hemostasis disorders].
    Riabov GA; Pasechnik IN; Azizov IuM
    Anesteziol Reanimatol; 2003; (1):69-74. PubMed ID: 12696462
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
    Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
    Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
    Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
    Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New methods in coagulation.
    Triplett DA
    Crit Rev Clin Lab Sci; 1981; 15(1):25-84. PubMed ID: 6459909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemostasis in diabetics.
    Misz M; Beck P; Udvardy M; Rák K
    Acta Med Hung; 1984; 41(2-3):93-102. PubMed ID: 6235479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective assessment of heparin requirements for hemodialysis in humans.
    Ireland H; Lane DA; Curtis JR
    J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of a simple radioimmunoassay for fibrinopeptide A.
    Walenga JM; Hoppensteadt D; Emanuele RM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):219-27. PubMed ID: 6515418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of polyethylene glycol to radioimmunoassays used in haemostasis.
    Woodhams BJ; Kernoff PB
    Thromb Res; 1983 Feb; 29(3):333-41. PubMed ID: 6189241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
    Papp AC; Hatzakis H; Bracey A; Wu KK
    Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.